Home Shop GW1929

GW1929

ALX-420-029

Datasheet
Manual
SDS
CofA

Already have an account?

PPARγ agonist

Potent (1’000-fold) PPARγ agonist which does not contain a thiazolidinedione moiety. The glucose-lowering effect of GW1929 in rats is 100-fold more potent than that of troglitazone (Prod. No. BML-GR210).

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Product Details

Alternative Name	N-(2-Benzoylphenyl)-L-tyrosine PPARγ Agonist, (2S)-((2-Benzoylphenyl)amino-3-[4-[2-(methylpyridin-2-ylamino)ethoxy]phenyl)propionic acid
Appearance	Off-white to yellow crystalline solid.
CAS	196808-24-9
Couple Target	PPAR
Couple Type	Activator, Ligand
Formula	C₃₀H₂₉N₃O₄
MW	495.6
Purity	≥97% (HPLC)
Solubility	Soluble in DMSO or methanol.

Handling & Storage

Use/Stability	As indicated on product label or CoA when stored as recommended.
Handling	Protect from light.
Long Term Storage	+4°C
Shipping	Ambient Temperature

Regulatory Status	RUO – Research Use Only

Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells: Liu, Q., Dai, Z., et al.; Acta Biochim. Biophys. Sin. (Shanghai) 42, 635 (2010), Abstract
Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes: Loo, L. H., Lin, H. J., et al.; J. Cell Biol. 187, 375 (2009), Abstract
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications: T.M. Lindström & P.R. Bennett; J. Clin. Endocrinol. Metab. 90, 3534 (2005), Abstract — Full Text
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929: W.C. Huang, et al.; Exp. Cell Res. 277, 192 (2002), Abstract
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents: B.R. Henke, et al.; J. Med. Chem. 41, 5020 (1998), Abstract

Related Products

Troglitazone

BML-GR210

PPAR ligand

12 citations

Alternative Name	(±)-5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione
CAS	97322-87-7
Couple Type	Ligand
Purity	≥98% (HPLC)

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Datasheet

Certificate of Analysis

Please enter the lot number as featured on the product label

Lot No. :

SDS

Enzo Life Science provides GHS Compliant SDS

English (EU) SDS

If your language is not available please fill out the SDS request form

Your Cart

Your Cart

GW1929

ALX-420-029

Product Details

Handling & Storage

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Certificate of Analysis

SDS

Change Country

Tell us about You

Tell us about your paper

Tell us about You

Tell us about your project